Lagha, Aymen <br/><br/>
[Impact of taxanes in the adjuvant setting of node-negative breast cancers].  [electronic resource] 

 -  Bulletin du cancer  May 2013 
 - 465-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1769-6917 
<br/><br/><label>Standard No.: </label>10.1684/bdc.2013.1743  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant--methods<br/>Clinical Trials as Topic<br/>Clinical Trials, Phase III as Topic<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Docetaxel<br/>Doxorubicin--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Lymph Nodes--pathology<br/>Methotrexate--administration & dosage<br/>Paclitaxel--administration & dosage<br/>Tamoxifen--administration & dosage<br/>Taxoids--administration & dosage